[Chemotherapy].
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001215:Asparaginase / Q000494:pharmacology; D001761:Bleomycin / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D003630:Daunorubicin / Q000494:pharmacology; D004358:Drug Therapy; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D007612:Kanamycin / Q000494:pharmacology; D010406:Penicillins / Q000494:pharmacology; D012293:Rifampin / Q000494:pharmacology; D014750:Vincristine / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D010406:Penicillins; D003561:Cytarabine; D001761:Bleomycin; D007612:Kanamycin; D014750:Vincristine; D001215:Asparaginase; D012293:Rifampin; D003630:Daunorubicin